Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo Search for Acquisitions Hampered by ‘Desperate’ Rivals
Bloomberg
Friday, September 25, 2009 - 8:36am
tags:
GSK, M&A
Pfizer and Eisai Continue Aricept Collaboration
Yahoo
Friday, September 25, 2009 - 8:28am
tags:
Pfizer, Eisai, Aricept
Battle for Solvay division nears end
FT.com
Thursday, September 24, 2009 - 10:08pm
tags:
Solvay, Abbott Laboratories, UCB Pharmaceuticals
Sector Snap: HIV vaccine developers
Yahoo/AP
Thursday, September 24, 2009 - 4:01pm
tags:
HIV, vaccines, GenVec, Inovio, Vical, Sanofi
Genzyme Struggles to Restore Order
Yahoo/Zacks.com
Thursday, September 24, 2009 - 4:00pm
tags:
Genzyme, Cerezyme, Fabrazyme
Wyeth's Biting the Hand That Feeds It
Motley Fool
Thursday, September 24, 2009 - 3:58pm
tags:
Wyeth, FDA, lawsuits, Zosyn, antibiotics
AstraZeneca loses appeal over drug wholesale price inflation lawsuit in Massachusetts
Yahoo/AP
Thursday, September 24, 2009 - 3:57pm
tags:
AstraZeneca, Massachusetts, Zoladex, drug prices
Mixed Data on Amgen's Vectibix
Yahoo/Zacks.com
Thursday, September 24, 2009 - 3:33pm
tags:
Amgen, Vectibix, Folfiri, cancer
Jazz and Transcept Pharmaceuticals on the Rise
Seeking Alpha
Thursday, September 24, 2009 - 11:23am
tags:
Jazz Pharmaceuticals, Transcept
In a stunner, Chelsea's hypotension drug flunks Phase III
Fierce Biotech
Thursday, September 24, 2009 - 11:20am
tags:
Chelsea Therapeutics, hypertension, drug trials, Droxidopa
Merck Gives $500 Million of Vaccine to Poorer Nations
Bloomberg
Thursday, September 24, 2009 - 11:17am
tags:
Merck, vaccines, donations, Gardasil
Bristol-Myers still hungry for deals after Medarex
Reuters
Thursday, September 24, 2009 - 11:15am
tags:
Bristol-Myers Squibb, Medarex, M&A
Abbott, UCB touted as bidders for Solvay's pharma division
Pharma Times, UK
Thursday, September 24, 2009 - 11:14am
tags:
Abbott Laboratories, UCB Pharmaceuticals, M&A, Solvay
Dendreon Investor Meeting: CFO Gives Provenge Sales Guidance
TheStreet.com
Thursday, September 24, 2009 - 11:05am
tags:
Dendreon, Provenge, prostate cancer
Playing Devil's Advocate on the Talecris IPO: A Banker Provides the Contrarian View
BNET Pharma
Thursday, September 24, 2009 - 11:04am
tags:
IPOs, Talecris
Cephalon gets priority review for jet-lag drug
Marketwatch
Thursday, September 24, 2009 - 11:02am
tags:
jet lag, Cephalon, NUVIGIL
AIDS Vaccine Found To Cut Risk of Getting HIV
TheStreet.com
Thursday, September 24, 2009 - 11:01am
tags:
AIDS, vaccines, HIV, Sanofi, VaxGen
Device Makers May Win Cut in Tax for Health Revamp
Bloomberg
Thursday, September 24, 2009 - 10:39am
tags:
healthcare reform, medical devices
Spectrum Pharmaceuticals: Undervalued and (Now) Oversold
Seeking Alpha
Thursday, September 24, 2009 - 10:38am
tags:
Spectrum Pharmaceuticals
Merck to publish GP payments
FT.com
Thursday, September 24, 2009 - 10:37am
tags:
Merck, physician payments

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.